会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Esophageal activity modulated obesity therapy
    • 食管活动调节肥胖症治疗
    • US08321030B2
    • 2012-11-27
    • US12763980
    • 2010-04-20
    • Jeremy ManiakJohann Neisz
    • Jeremy ManiakJohann Neisz
    • A61N1/36
    • A61N1/36007A61N1/0551
    • Methods and devices for delivering electrical stimulation to the sympathetic nervous system in response to the onset of eating. In some methods, swallowing is detected which then initiates a dose of stimulation which can vary in intensity, frequency, or both over the dose length. In some methods, the dose length is between about one quarter hour and one hour. The dose frequency may increase, hold steady, then decrease over the dose duration so as to mimic the response of the gut stretch and nutrient receptors to receiving food. The dose can drive biomarkers indicative of eating, for example glucagon, glucose, FFA or glycerol to at least about half of their normal post eating levels and then stop so as to retain stimulation effectiveness for subsequent doses and to prolong battery life.
    • 用于向交感神经系统递送电刺激以响应于进食的方法和装置。 在一些方法中,检测吞咽,然后开始剂量的刺激,其可以在剂量长度上强度,频率或两者都变化。 在一些方法中,剂量长度在约四分之一小时至一小时之间。 剂量频率可能增加,保持稳定,然后在剂量持续时间内减少,以模拟肠道拉伸和营养受体对接受食物的反应。 该剂量可以将指示进食的生物标志物(例如胰高血糖素,葡萄糖,FFA或甘油)驱动至其正常饮食水平的至少约一半,然后停止,以保持后续剂量的刺激效果并延长电池寿命。
    • 8. 发明申请
    • ESOPHAGEAL ACTIVITY MODULATED OBESITY THERAPY
    • 食疗活性调节性肥胖治疗
    • US20100268306A1
    • 2010-10-21
    • US12763980
    • 2010-04-20
    • Jeremy ManiakJohann Neisz
    • Jeremy ManiakJohann Neisz
    • A61N1/36
    • A61N1/36007A61N1/0551
    • Methods and devices for delivering electrical stimulation to the sympathetic nervous system in response to the onset of eating. In some methods, swallowing is detected which then initiates a dose of stimulation which can vary in intensity, frequency, or both over the dose length. In some methods, the dose length is between about one quarter hour and one hour. The dose frequency may increase, hold steady, then decrease over the dose duration so as to mimic the response of the gut stretch and nutrient receptors to receiving food. The dose can drive biomarkers indicative of eating, for example glucagon, glucose, FFA or glycerol to at least about half of their normal post eating levels and then stop so as to retain stimulation effectiveness for subsequent doses and to prolong battery life.
    • 用于向交感神经系统递送电刺激以响应于进食的方法和装置。 在一些方法中,检测吞咽,然后开始剂量的刺激,其可以在剂量长度上强度,频率或两者都变化。 在一些方法中,剂量长度在约四分之一小时至一小时之间。 剂量频率可能增加,保持稳定,然后在剂量持续时间内减少,以模拟肠道拉伸和营养受体对接受食物的反应。 该剂量可以将指示进食的生物标志物(例如胰高血糖素,葡萄糖,FFA或甘油)驱动至其正常饮食水平的至少约一半,然后停止,以保持后续剂量的刺激效果并延长电池寿命。